U.S. Stock News

NYSE:LAD
NYSE:LADSpecialty Retail

Is Lithia Motors (LAD) Pricing Look Attractive After Recent Share Price Rebound

If you are wondering whether Lithia Motors at around US$290.90 is a bargain or a value trap, a good starting point is understanding how its current share price compares to different measures of fair value. The stock has recently seen a 5.8% move over 7 days and a 16.0% change over 30 days, while the return year to date is a 12.5% decline and the 1 year return is a 1.1% decline, with a 37.5% gain over 3 years and a 20.9% decline over 5 years. Recent news coverage has focused on Lithia Motors...
NasdaqGS:FWON.K
NasdaqGS:FWON.KEntertainment

Formula One Group’s Pacsun Tie Up Extends Fashion Story For FWON.K

Formula One Group and Pacsun announced an official Formula 1 Miami Grand Prix 2026 Collection, expanding F1 branded fashion into the U.S. retail market. The collection focuses on race inspired designs and is tied to the Miami Grand Prix weekend, targeting Gen Z and millennial shoppers. The move reflects Formula One Group's push to extend its brand into lifestyle and streetwear beyond the core motorsports audience. For investors tracking NasdaqGS:FWON.K, this Pacsun collaboration adds...
NYSE:ATMU
NYSE:ATMUMachinery

Atmus Filtration Technologies (ATMU) Margin Strength Supports Bullish Narratives Heading Into Q1 2026

Atmus Filtration Technologies (ATMU) has just put fresh numbers on the board for Q1 2026, coming off a recent quarter where Q4 2025 revenue was US$446.6 million and basic EPS was US$0.59, backed by trailing 12 month EPS of US$2.52 and net income of US$207.4 million. Over the past year, the company has seen revenue move from US$406.7 million in Q4 2024 to US$446.6 million in Q4 2025, while quarterly EPS shifted from US$0.48 to US$0.59, setting up this latest print against a backdrop of higher...
NYSE:EL
NYSE:ELPersonal Products

Estée Lauder (EL) Returns To Quarterly Profit As EPS Recovery Tests Bearish Narratives

Estée Lauder Companies (EL) has put fresh numbers on the table for its latest quarter, with Q2 2026 revenue of US$4.2b and basic EPS of US$0.45, set against a trailing twelve month picture that still shows a basic EPS loss of US$0.49 on revenue of US$14.7b. Over recent quarters, the company has seen revenue move between US$3.4b and US$4.0b in fiscal 2025, before reaching US$3.5b in Q1 2026 and US$4.2b in Q2 2026. Basic EPS has ranged from losses of around US$1.64 per share to a recent profit...
NYSE:AOS
NYSE:AOSBuilding

A. O. Smith Cuts 2026 Outlook As China Weakness And U.S. Issues Bite

A. O. Smith (NYSE:AOS) reported Q1 2026 results that missed expectations, citing weak demand in China and production issues at its Ashland City facility. The company lowered its full-year 2026 guidance for both sales and earnings, reflecting softer performance and operational challenges. Management outlined a targeted restructuring of the North America water treatment business and plans for price increases to address higher input costs. A. O. Smith, a manufacturer of water heaters and water...
NYSE:DBRG
NYSE:DBRGCapital Markets

A Look At DigitalBridge Group (DBRG) Valuation After Strong 1-Year Returns And Mixed Multiple Signals

DigitalBridge Group (DBRG) continues to draw attention as investors weigh its role in digital infrastructure against recent share performance. The stock last closed at US$15.55 and has a market value of about US$2.9b. See our latest analysis for DigitalBridge Group. While the recent 1-day and 7-day share price returns are slightly negative, DigitalBridge Group’s 1-year total shareholder return of 69.55% contrasts with a 5-year total shareholder return decline of 43.82%. This suggests momentum...
NasdaqGS:APLS
NasdaqGS:APLSBiotechs

Apellis Cell And Gene Update Puts Growth Story In Investor Focus

Apellis Pharmaceuticals (NasdaqGS:APLS) is scheduled to present at the 2026 Cell & Gene Meeting on the Mediterranean. The conference appearance will focus on the company’s cell and gene therapy programs. The event is expected to draw interest from biotech specialists and investors who track emerging therapeutic platforms. Apellis Pharmaceuticals (NasdaqGS:APLS) is known for work in complement biology, and its upcoming presence at the 2026 Cell & Gene Meeting on the Mediterranean puts a...
NYSE:SAH
NYSE:SAHSpecialty Retail

Is Sonic Automotive (SAH) Getting Ahead Of Itself After Strong Recent Share Price Gains

Wondering whether Sonic Automotive's current share price lines up with its underlying value, or if the recent attention has run ahead of the fundamentals? The stock last closed at US$76.43, with returns of 6.4% over 7 days, 17.1% over 30 days, 24.0% year to date, 24.5% over 1 year, 101.2% over 3 years and 64.1% over 5 years. These figures may catch the eye of investors reviewing performance over different time frames. Recent coverage of US auto retailers has focused on how dealers are...
NYSE:OGN
NYSE:OGNPharmaceuticals

Organon Buyout And POHERDY Approval Shape Returns And Valuation Outlook

Organon (NYSE:OGN) has agreed to be acquired by Sun Pharmaceutical Industries in an all cash deal valued at about $11.75b. The transaction is expected to close in early 2027, after which Organon is set to be delisted from the NYSE. Separately, Organon and Henlius have received European marketing approval for POHERDY, the first biosimilar to PERJETA. For investors watching NYSE:OGN, these developments arrive after a sharp recent move in the share price. The stock closed at $13.29, with...
NYSE:HCC
NYSE:HCCMetals and Mining

Warrior Met Coal (HCC) Q1 EPS Rebound Challenges Bearish Profitability Narratives

Warrior Met Coal (HCC) opened Q1 2026 with total revenue of US$458.6 million and basic EPS of US$1.37, alongside net income of US$72.3 million, as the market weighs these fresh numbers against a current share price of US$86.20. Over the last six reported quarters, the company has seen quarterly revenue move from US$297.5 million in Q4 2024 to US$302.6 million in Q1 2025 and then to US$458.6 million in Q1 2026. Basic EPS shifted from US$0.02 in Q4 2024 to a loss of US$0.16 in Q1 2025 and then...
NYSE:RHP
NYSE:RHPHotel and Resort REITs

Ryman Hospitality Properties (RHP) Q1 2026 Earnings Highlight Dividend And Interest Coverage Concerns

Ryman Hospitality Properties (RHP) started 2026 with Q1 revenue of $664.6 million and basic EPS of $1.12, alongside trailing twelve month revenue of $2.6 billion and EPS of $4.01 that frame the latest quarter in a broader context. Over the past year, revenue has moved from $2.3 billion in the 2024 Q4 trailing period to $2.6 billion in the latest trailing snapshot, while basic EPS has tracked between $4.54 and $4.01 over those same intervals. This gives investors a clearer view of the earnings...
NasdaqGS:TEAM
NasdaqGS:TEAMSoftware

Atlassian (TEAM) Q3 Loss Deepens To US$98m And Tests Bullish Profitability Narrative

Atlassian (TEAM) just posted Q3 2026 results with revenue of US$1.8 billion, a basic EPS loss of US$0.38 and net income loss of US$98.4 million, setting the tone for another quarter where growth and profitability remain in tension. The company has seen quarterly revenue move from US$1.36 billion in Q3 2025 to US$1.79 billion in Q3 2026. Over that span, basic EPS ranged from a loss of US$0.27 in Q3 2025 to a loss of US$0.38 in the latest quarter, leaving investors focused squarely on how...
NYSE:PEN
NYSE:PENMedical Equipment

Is Penumbra (PEN) Pricing In Too Much Growth After Recent Trial Developments

Wondering if Penumbra at around US$325.33 is offering you real value or just a rich price tag? This article walks through what the latest numbers actually say about the stock. The share price shows a 1.4% decline over the last 7 days and a 1.1% decline over the last 30 days, while returns stand at 5.1% year to date and 9.9% over the past year. Recent coverage around Penumbra has focused on its position in the medical equipment space and how investors are weighing growth potential against...
NYSE:APAM
NYSE:APAMCapital Markets

Artisan Partners Weighs Acquisitions And New Credit Strategies With Excess Capital

Artisan Partners Asset Management (NYSE:APAM) is signaling a push into acquisitions and new investment strategies in differentiated credit, private equity and real assets. Management has highlighted an active M&A pipeline, interest in both individual hires and larger deals, and continued R&D efforts to expand the firm’s platform. The company plans to pursue these opportunities while keeping significant excess capital available for potential transactions and organic growth...
NasdaqGS:ZION
NasdaqGS:ZIONBanks

Is Zions Bancorporation (ZION) Still Attractively Priced After Strong Three Year Share Gains

If you are wondering whether Zions Bancorporation National Association is priced attractively right now, it helps to start with what the recent share performance and valuation checks are signaling. The stock last closed at US$63.26, with returns of 3.1% over 7 days, 8.6% over 30 days, 6.8% year to date, 40.3% over 1 year and 199.5% over 3 years, while the 5 year return stands at 26.7%. Recent headlines around US banks, including Zions Bancorporation National Association, have focused on...
NYSE:HIW
NYSE:HIWOffice REITs

Is It Time To Reassess Highwoods Properties (HIW) After Its Recent Share Price Rebound?

Investors may be wondering whether Highwoods Properties at around US$24.71 is starting to look like value, or if the price still does not quite stack up. The stock has recently shown mixed returns, with a 3.4% gain over 7 days and 15.4% over 30 days, set against a 4.5% decline year to date and an 8.9% decline over the past year. Recent coverage has focused on how office focused real estate investment trusts fit into investors' portfolios as hybrid work patterns and demand for office space...
NYSE:CR
NYSE:CRMachinery

Crane Q1 Acquisition Gains Support Higher 2026 Guidance And Growth Plans

Crane Company (NYSE:CR) reported a strong Q1 2026, with net sales supported by the integration of several recent acquisitions. Management raised full year 2026 guidance and outlined plans for further M&A, citing a solid acquisition pipeline and balance sheet. The company is targeting significant total sales growth for 2026, with recent deals already contributing earlier than initially expected. Crane Company, traded as NYSE:CR, operates as a diversified industrial business, supplying...
NasdaqGS:VTRS
NasdaqGS:VTRSPharmaceuticals

Viatris Contraceptive Patch Data Puts Women’s Health Growth Story In Focus

Viatris (NasdaqGS:VTRS) is presenting pivotal Phase 3 results for its investigational low dose estrogen contraceptive weekly patch at a major scientific meeting. The U.S. FDA has accepted the New Drug Application for the patch and set a target action date in July 2026. The product is positioned within Viatris' women's health franchise and represents a potential new entrant in the contraceptive market. For investors tracking NasdaqGS:VTRS, this contraceptive patch sits within a broader...
NasdaqGS:ROKU
NasdaqGS:ROKUEntertainment

Roku (ROKU) Profitability Turnaround Challenges Bearish Earnings Narratives

Roku (ROKU) has just opened 2026 earnings season with Q1 results that build on a clear turnaround in the numbers, capped by Q4 2025 revenue of about US$1.4b and basic EPS of US$0.54. Over the past year, quarterly revenue has moved from US$1,201.0m in Q4 2024 to US$1,394.9m in Q4 2025, while basic EPS shifted from a loss of US$0.24 to a profit of US$0.54. This sets up a story in which improving profitability sits at the center of the earnings debate, with margins in focus as investors weigh...
NasdaqGS:SRAD
NasdaqGS:SRADHospitality

Is Sportradar Group (SRAD) Pricing Look Compelling After Recent Share Price Slide

Wondering whether Sportradar Group's current share price reflects its true worth, or if the market is mispricing the story. The stock last closed at US$13.26, with returns of 0.2% over 7 days, a 20.3% decline over 30 days, and year to date and 1 year returns of 43.1% and 44.1% declines, while the 3 year return sits at 1.8%. Recent coverage has focused on Sportradar Group as a listed sports data and technology provider, with attention on how it is positioned in the wider sports betting and...
NYSE:FR
NYSE:FRIndustrial REITs

First Industrial Adds Director After Activist Push What It Means For FR

First Industrial Realty Trust expanded its board and appointed Frank E. Schmitz as an independent director. The move follows a recent activist investor campaign focused on board composition and governance. The appointment comes in a contested board setting, signaling a response to shareholder pressure. For investors watching NYSE:FR, this board change occurs at a time when the stock is trading at $62.14 and has returned 31.2% over the past year and 44.6% over the past five years. Those...
NasdaqGS:GEN
NasdaqGS:GENSoftware

Gen Digital Targets AI Trust Layer With xAI Tie Up And VPN For Agents

Gen Digital (NasdaqGS:GEN) has partnered with xAI to bring Grok large language models into its consumer platforms via the Gen AI Foundry. The company is launching VPN for Agents, presented as an industry first security tool tailored to autonomous AI agents. Gen Digital is also expanding Norton AI Agent Protection to address new cyber risks created by AI driven agents. Gen Digital, trading at $19.37, is adding these AI focused efforts on top of a share performance record that includes a...
NasdaqGS:UCTT
NasdaqGS:UCTTSemiconductor

Ultra Clean Updates Board Leadership As AI Cycle Shapes Capital Choices

Ultra Clean Holdings (NasdaqGS:UCTT) announced that Clarence Granger will step down as Chairman of the Board effective May 22, 2026. Tom Edman has been appointed to assume the Chairman role as the company adjusts its leadership at the board and executive levels. This change follows a period of executive transitions while the sector is influenced by increased AI related investment. Ultra Clean Holdings, trading at $74.61, has seen sharp share price moves recently, including a 10.1% decline...
NYSE:CALY
NYSE:CALYLeisure

Is It Too Late To Reassess Callaway Golf (CALY) After Its Recent Share Price Surge

If you are wondering whether Callaway Golf at around US$15.16 is still reasonably priced after its recent run, the valuation story is the key place to focus. The stock has seen sharp moves, with a 29.4% return year to date and 121.3% over the last year, set against a 32.1% decline over three years and a 51.3% decline over five years. These swings have kept Callaway Golf on many watchlists, as investors weigh shorter term momentum of 9.7% over the last 30 days against a 1% decline over the...